CCN1C(=O)[C@H]2[C@@H](C)C3=C4C([C@H](C(=O)OC)C=C(C(=O)OC)C[C@H]4[C@H]2C1=O)C(CC)(CC)C3=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?